SPY334.89+2.52 0.76%
DIA277.50+3.08 1.12%
IXIC11,167.51+82.26 0.74%

Citigroup Maintains Buy on Cidara Therapeutics, Lowers Price Target to $5

Citigroup maintains Cidara Therapeutics (NASDAQ:CDTX) with a Buy and lowers the price target from $6 to $5.

 · 
Citigroup maintains Cidara Therapeutics (NASDAQ:CDTX) with a Buy and lowers the price target from $6 to $5.